Citation Impact
Citing Papers
Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting
2009
Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
2000
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome
2007
Acute kidney injury
2012 Standout
Diabetic retinopathy
2010 Standout
Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease
2006
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
2001
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency
2008
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
n–3 Fatty Acids in Cardiovascular Disease
2011
Baseline Predictors of Renal Disease Progression in the African American Study of Hypertension and Kidney Disease
2006
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists
2006
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure
2002
Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking
2004
Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals
2002
Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
2009
Anemia and left ventricular hypertrophy in chronic kidney disease populations: A review of the current state of knowledge
2002
Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction
2011
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients
2004
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Acute kidney injury
2019 Standout
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options
2018
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft Intervention
2010
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
2006
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Cardiorenal Syndrome
2008 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Cardiovascular disease in chronic renal insufficiency
2000
Myocarditis
2011 Standout
The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients
2003
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Sex, haemoglobin and kidney disease: new perspectives
2005
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Etiology of Anemia in Patients With Advanced Heart Failure
2006
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study
2003
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
2010
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
2003
Erythropoietin: ready for prime-time cardioprotection
2008
A novel protective effect of erythropoietin in the infarcted heart
2003
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction
2001
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Once-Monthly Administration of Darbepoetin Alfa for the Treatment of Patients with Chronic Heart Failure and Anemia
2005
Type 2 diabetes mellitus
2015 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency
2007
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012 Standout
Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
2009
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Effect of Darbepoetin Alfa on Exercise Tolerance in Anemic Patients With Symptomatic Chronic Heart Failure
2007
Nephropathy in Patients with Type 2 Diabetes Mellitus
1999
Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure
2005
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches
2011
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effect of a Chicken-Based Diet on Renal Function and Lipid Profile in Patients With Type 2 Diabetes
2002
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Erythropoietin regulates endothelial progenitor cells
2003
Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure
2003
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
2008
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
2004 StandoutNobel
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Hemodilution Is Common in Patients With Advanced Heart Failure
2003
The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency
2003
E-Syts, a family of membranous Ca 2+ -sensor proteins with multiple C 2 domains
2007 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
2015
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
Iron-Deficiency Anemia
2015 Standout
Phosphatidylinositol-3-Kinase Signaling Is Required for Erythropoietin-Mediated Acute Protection Against Myocardial Ischemia/Reperfusion Injury
2004 StandoutNobel
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000
Diabetic Retinopathy
2004
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Anemia in Chronic Heart Failure
2006
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia
2008
Works of David Brosh being referenced
Effect of Clopidogrel Pretreatment on Angiographic and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction
2007
The impact of renal insufficiency on patients outcomes in emergent angioplasty for acute myocardial infarction
2006
Major bleeding complicating contemporary primary percutaneous coronary interventions—incidence, predictors, and prognostic implications
2009
Drug‐eluting stents in bifurcation lesions: To stent one branch or both?
2006
Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia
1998
Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions
2008
Mild renal insufficiency is associated with reduced coronary flow in patients with non-obstructive coronary artery disease
2006
Treatment of Aspirin-Resistant Patients With Omega-3 Fatty Acids Versus Aspirin Dose Escalation
2010
Effect of No-Reflow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction on Six-Month Mortality
2006
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
2000